financetom
Business
financetom
/
Business
/
Nutrien to sell 50% stake in Profertil for $600 million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nutrien to sell 50% stake in Profertil for $600 million
Sep 8, 2025 4:21 AM

Sept 8 (Reuters) - Nutrien ( NTR ) said on Monday it

will sell its 50% stake in Argentina-based nitrogen producer

Profertil S.A. for $600 million as the top potash producer looks

to rein in expenses and shift focus to other key markets.

(Reporting by Sumit Saha in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equitable Holdings Insider Sold Shares Worth $1,912,224, According to a Recent SEC Filing
Equitable Holdings Insider Sold Shares Worth $1,912,224, According to a Recent SEC Filing
Oct 21, 2025
04:52 PM EDT, 10/21/2025 (MT Newswires) -- Mark Pearson, Director, President and CEO, on October 20, 2025, sold 39,700 shares in Equitable Holdings ( EQH ) for $1,912,224. Following the Form 4 filing with the SEC, Pearson has control over a total of 689,040 common shares of the company, with 689,040 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1333986/000162828025045723/xslF345X05/wk-form4_1761079619.xml ...
EQT Corp beats quarterly profit estimates on higher natural gas prices
EQT Corp beats quarterly profit estimates on higher natural gas prices
Oct 21, 2025
Oct 21 (Reuters) - U.S.-based energy company EQT Corp ( EQT ) beat Wall Street estimates for third-quarter profit on Tuesday, benefiting from higher natural gas prices and sales volumes. The demand for and output of U.S. natural gas are expected to hit record highs in 2025, according to the Energy Information Administration's Short-Term Energy Outlook. The energy sector has...
Terns Pharma ends obesity drug program after mid-stage trial data
Terns Pharma ends obesity drug program after mid-stage trial data
Oct 21, 2025
Oct 21 (Reuters) - Terns Pharmaceuticals ( TERN ) said on Tuesday it will stop developing its experimental obesity drug after a mid-stage trial showed modest weight loss and raised safety concerns. ...
DraftKings Stock Surges Following Acquisition To Launch Prediction Markets
DraftKings Stock Surges Following Acquisition To Launch Prediction Markets
Oct 21, 2025
DraftKings Inc ( DKNG ) shares are rising in extended trading on Tuesday after the company announced an acquisition to support its entry into prediction markets. What To Know: DraftKings ( DKNG ) will acquire Railbird Technologies and its wholly owned subsidiary, Railbird Exchange, a federally licensed exchange designated by the Commodity Futures Trading Commission.  The acquisition is expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved